Oblongine
From DrugPedia: A Wikipedia for Drug discovery
(Difference between revisions)
m (1 revision) |
(→Description) |
||
| Line 25: | Line 25: | ||
==Description== | ==Description== | ||
from Leontice leontopetalum; RN given refers to parent cpd without isomeric designation | from Leontice leontopetalum; RN given refers to parent cpd without isomeric designation | ||
| + | |||
| + | Oblongine chloride may have potential haemodynamic effects and that these effects are not mediated by β-adrenergic receptor stimulation. | ||
==General Properties== | ==General Properties== | ||
Current revision
| Oblongine
| |
| Systematic (IUPAC) name | |
| (1S)-1-[(4-hydroxyphenyl)methyl]-7-methoxy-2,2-dimethyl-3,4-dihydro-1H-isoquinolin-2-ium-8-ol | |
| Identifiers | |
| CAS number | ? |
| ATC code | ? |
| PubChem | |
| Chemical data | |
| Formula | C19H24NO3+ |
| Mol. mass | 314.39876 |
| SMILES | & |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | ? |
| Half life | ? |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status | |
| Routes | ? |
[edit] Description
from Leontice leontopetalum; RN given refers to parent cpd without isomeric designation
Oblongine chloride may have potential haemodynamic effects and that these effects are not mediated by β-adrenergic receptor stimulation.
[edit] General Properties
*Molecular Weight
314.39876
*Molecular Formula
C19H24NO3+
*IUPAC NAME
(1S)-1-[(4-hydroxyphenyl)methyl]-7-methoxy-2,2-dimethyl-3,4-dihydro-1H-isoquinolin-2-ium-8-ol
*Canonical Smiles
C[N+]1(CCC2=C(C1CC3=CC=C(C=C3)O)C(=C(C=C2)OC)O)C
*Isomeric Smiles
C[N+]1(CCC2=C([C@@H]1CC3=CC=C(C=C3)O)C(=C(C=C2)OC)O)C
*XLogP
N/A
*Topological Polar Surface Area
49.7
